mixed connective tissue disease: Mixed connective tissue disease (MCTD) is a rare autoimmune disorder that is characterized by features commonly seen in three different connective tissue disorders: systemic lupus erythematosus , scleroderma , and polymyositis . Some affected people may also have symptoms of rheumatoid arthritis . Although MCTD can affect people of all ages, it appears to be most common in women under age 30. Signs and symptoms vary but may include Raynaud's phenomenon ; arthritis; heart, lung and skin abnormalities; kidney disease; muscle weakness, and dysfunction of the esophagus. The cause of MCTD is currently unknown. There is no cure but certain medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) , corticosteroids and immunosuppresivedrugsmay help manage the symptoms.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
667 |
4. Check minimum number of eventsNone |
667 |
5. Include endpointsNone |
667 |
6. Filter based on genotype QC (FinnGen only) |
667 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M35
- Name in latin
- Alia syndromata mixta
Similar endpoints
↥List of similar endpoints to
Other overlap syndromes
based on the number of shared cases.
Similar with more cases:
- Mixed connective tissue disease
- Other systemic involvement of connective tissue (FG)
- Other systemic involvement of connective tissue
- Systemic connective tissue disorders
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3427 | 2668 | 727 |
| Only index persons | 3153 | 2488 | 665 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.08 | 0.02 |
| Only index persons | 0.08 | 0.09 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 55.82 | 55.40 | 57.44 |
| Only index persons | 55.07 | 54.63 | 56.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 667 | 514 | 153 |
| Unadjusted period prevalence (%) | 0.15 | 0.18 | 0.07 |
| Median age at first event (years) | 52.71 | 50.78 | 59.19 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 605
- Matched controls
- 6048
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P01BA02
ATC
hydroxychloroquine; oral
55.3
323.0
412
224
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
323.0
605
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
44.2
312.2
417
288
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
370.5
169.0
163
6
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2100.6
167.8
155
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
19.2
165.5
275
251
H02AB06
ATC
prednisolone; systemic
10.0
128.9
501
1972
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
18.6
126.9
207
164
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.6
100.2
402
1400
L04AX01
ATC
azathioprine; systemic
21.3
98.6
150
92
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
92.1
86
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
455.7
82.0
80
*
C08CA05
ATC
nifedipine; systemic
12.7
81.2
154
158
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
11.8
80.0
158
176
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
13.2
61.4
112
102
XX9XE
NOMESCO Finland
Other ultrasound examination
76.3
60.6
68
10
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.0
59.6
135
186
H02AB07
ATC
prednisone; oral
5.7
57.9
194
463
M35.3
ICD-10 Finland
Polymyalgia rheumatica
23.8
56.2
81
39
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
55.1
364
1677
L88
ICPC
Rheumatoid/seropositive arthritis
14.1
52.9
93
77
PAW37
NOMESCO Finland
Biopsy of temporal artery
482.2
45.9
45
*
M05BA04
ATC
alendronic acid; oral
6.0
43.7
132
268
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
8.1
42.8
102
148
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
6.0
42.6
128
257
L04AA06
ATC
mycophenolic acid; systemic
22.5
41.9
61
30
I73.0
ICD-10 Finland
Raynaud syndrome
25.6
38.7
54
23
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
37.9
36
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
35.3
251
1098
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.0
31.9
75
105
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
30.5
29
*
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
+∞
29.4
28
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.3
28.7
175
669
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
28.3
27
*
R50.9
ICD-10 Finland
Fever, unspecified
3.6
27.2
140
467
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
25.0
169
682
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
12.1
24.1
44
39
XPX04
NOMESCO Finland
Angioscopy
56.4
23.2
27
5
A02BC02
ATC
pantoprazole; systemic
2.5
23.1
435
3071
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
+∞
23.1
22
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
23.1
22
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
22.3
308
1848
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.7
21.6
47
58
M13.9
ICD-10 Finland
Arthritis, unspecified
4.7
21.5
76
178
R4120
NOMESCO Finland
Occupational therapy
4.5
20.9
77
188
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.0
20.7
69
152
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
7.8
20.6
48
66
H04.10
ICD-10 Finland
Dry eye syndrome
3.6
20.3
99
312
ZX120
NOMESCO Finland
Intravenous
3.7
20.0
94
287
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.8
19.1
86
253
SBA10
NOMESCO Finland
Measurement of excretion of saliva
16.5
19.0
30
19
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.6
18.6
38
42
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
8.4
18.6
41
52
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
18.3
134
556
M35.5
ICD-10 Finland
Multifocal fibrosclerosis
+∞
17.8
17
*
7108X
ICD-9 Finland
Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue
+∞
17.8
17
*
A02BC03
ATC
lansoprazole; oral
2.3
17.6
214
1168
E0000UV
ATC
NA
2.1
17.1
273
1680
XG410
NOMESCO Finland
Flow-volume spirometry
5.8
17.0
49
91
M05BA07
ATC
risedronic acid; oral
5.8
17.0
49
91
R06.0
ICD-10 Finland
Dyspnoea
2.4
16.8
182
935
L04AA13
ATC
leflunomide; oral
7.1
16.8
41
61
M33.2
ICD-10 Finland
Polymyositis
+∞
16.7
16
*
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
16.7
16
*
H02AB04
ATC
methylprednisolone; systemic
2.8
16.7
123
513
C08CA02
ATC
felodipine; oral
3.5
16.4
80
251
A02BC01
ATC
omeprazole; systemic
2.3
16.4
198
1073
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
16.3
105
402
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
15.7
84
282
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.5
15.6
135
613
I77.6
ICD-10 Finland
Arteritis, unspecified
87.4
15.6
17
*
L04AD01
ATC
ciclosporin; systemic
11.2
15.6
29
27
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
39.1
15.5
19
5
A07EC01
ATC
sulfasalazine; oral, rectal
3.5
15.3
75
236
N02AX02
ATC
tramadol; systemic, rectal
2.0
15.2
271
1723
L04AA01
ATC
[U] ciclosporin; systemic
10.4
15.1
29
29
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.6
14.6
69
211
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
14.4
148
734
A07AA02
ATC
nystatin; oral
3.8
14.3
63
181
J01FF01
ATC
clindamycin; systemic
2.2
14.2
184
1017
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.1
13.9
82
294
TGC00
NOMESCO Finland
Bronchial lavation
7.9
13.8
31
41
WZA10
NOMESCO Finland
Long statement of health and health related matters
12.4
13.7
24
20
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
13.6
13
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
13.6
13
*
M35
ICD-10 Finland
Other systemic involvement of connective tissue
143.0
13.5
14
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
13.4
80
290
TEA00
NOMESCO Finland
Biopsy of lip
19.6
13.0
19
10
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
5.6
12.9
37
69
NH3EA
NOMESCO Finland
Feet X-ray examination with load
6.7
12.8
32
50
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.1
12.8
74
263
M35.7
ICD-10 Finland
Hypermobility syndrome
32.8
12.6
16
5
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.0
12.6
77
284
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
12.5
12
*
P01BA01
ATC
chloroquine; systemic
24.9
12.5
17
7
A02BC05
ATC
esomeprazole; systemic
1.9
12.1
265
1769
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
12.1
54
158
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.5
11.9
42
99
J01MA14
ATC
moxifloxacin; systemic
3.2
11.7
65
222
C03CA01
ATC
furosemide; systemic
2.0
11.7
167
949
C08CA01
ATC
amlodipine; oral
1.9
11.7
210
1303
NXL00
NOMESCO Finland
Biopsy of muscle
66.2
11.6
13
*
L01AA01
ATC
cyclophosphamide; systemic
66.2
11.6
13
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.9
11.6
28
42
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
11.5
56
175
J01MA12
ATC
levofloxacin; systemic
2.3
11.5
120
594
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.8
11.5
38
84
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
8.1
11.5
25
32
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
11.2
152
844
M01AH01
ATC
celecoxib; oral (coxibs)
2.2
11.2
131
682
M05BX04
ATC
denosumab; parenteral
3.7
11.1
48
137
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.1
11.0
62
216
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
7.1
11.0
26
38
A02BA02
ATC
ranitidine; systemic
2.1
10.9
135
719
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.1
10.8
60
206
J01DB01
ATC
cefalexin; oral
2.0
10.7
499
4232
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.8
10.7
45
125
M60.9
ICD-10 Finland
Myositis, unspecified
21.9
10.7
15
7
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
13.2
10.7
18
14
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
9.4
10.6
21
23
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
111.8
10.4
11
*
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
10.4
10
*
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
10.4
10
*
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
10.4
10
*
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
+∞
10.4
10
*
M31.6
ICD-10 Finland
Other giant cell arteritis
+∞
10.4
10
*
M13.0
ICD-10 Finland
Polyarthritis, unspecified
9.8
10.3
20
21
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
9.8
10.3
20
21
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.2
10.2
53
175
D07AC01
ATC
betamethasone; topical
1.8
10.2
222
1458
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.0
10.1
58
205
M01AC06
ATC
meloxicam; systemic, rectal
1.8
10.1
235
1578
UJF32
NOMESCO Finland
Coloscopy
2.0
10.1
157
917
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
6.1
9.9
26
44
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
9.9
170
1028
L93.0
ICD-10 Finland
Discoid lupus erythematosus
20.4
9.8
14
7
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
9.8
88
403
G04BE03
ATC
sildenafil; oral
13.6
9.7
16
12
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.9
9.7
39
105
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.8
9.6
31
67
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
9.5
79
348
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
9.4
67
272
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
9.4
9
*
M32
ICD-10 Finland
Systemic lupus erythematosus
+∞
9.4
9
*
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
9.4
9
*
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
9.4
9
*
L20
ICPC
Joint symptom/complaint NOS
4.4
9.3
33
79
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.5
9.3
21
29
UJF30
NOMESCO Finland
Ileoscopy through colon
2.6
9.3
69
287
TNG10
NOMESCO Finland
Puncture of knee
11.7
9.1
16
14
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.5
9.0
31
72
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
7.6
9.0
20
27
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
6.1
8.8
23
39
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
9.7
8.8
17
18
A01AB04
ATC
amphotericin B; local oral
3.3
8.7
43
137
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
8.7
180
1148
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
8.7
55
207
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.2
8.7
26
52
M25.5
ICD-10 Finland
Pain in joint
1.8
8.7
181
1161
K11.2
ICD-10 Finland
Sialoadenitis
4.0
8.7
33
85
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
8.6
251
1783
L99
ICPC
Musculoskeletal disease other
6.4
8.4
21
34
M01AH02
ATC
rofecoxib; oral
2.2
8.4
92
462
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
8.7
8.3
17
20
J02AC01
ATC
fluconazole; systemic
1.7
8.3
275
2017
N03AX16
ATC
pregabalin; oral
1.8
8.3
154
948
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
14.7
8.2
13
9
M05BB03
ATC
alendronic acid and colecalciferol; oral
4.8
8.2
26
56
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.6
8.1
27
61
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.6
8.1
35
101
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
8.1
58
235
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
5.4
8.1
23
44
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
8.1
31
81
J01MA02
ATC
ciprofloxacin; systemic
1.7
8.0
221
1535
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
7.9
110
611
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
7.8
37
116
ELA30
NOMESCO Finland
Biopsy of salivary gland
45.6
7.7
9
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.1
7.7
28
70
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
7.7
85
428
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.5
7.6
34
101
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
18.6
7.6
11
6
K11.70
ICD-10 Finland
Hypoptyalism
12.0
7.6
13
11
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.4
7.6
35
107
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
6.6
7.5
18
28
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
7.4
54
221
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
81.0
7.4
8
*
C02KX01
ATC
bosentan; oral
81.0
7.4
8
*
C02KX04
ATC
macitentan; oral
81.0
7.4
8
*
R1250
NOMESCO Finland
Evaluation of functional capability
5.7
7.4
20
36
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.7
7.4
20
36
D68.8
ICD-10 Finland
Other specified coagulation defects
8.5
7.4
15
18
M01AB55
ATC
diclofenac, combinations; oral
2.7
7.3
50
198
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
7.3
7
*
M35.2
ICD-10 Finland
Behçet disease
+∞
7.3
7
*
M01AH05
ATC
etoricoxib; oral
1.6
7.3
344
2733
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
7.3
59
256
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
7.2
209
1462
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.3
7.2
34
106
R4110
NOMESCO Finland
Physiotherapy
1.7
7.2
157
1010
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
20.3
7.1
10
5
H02AB09
ATC
hydrocortisone; systemic
4.6
7.1
23
51
N06AX21
ATC
duloxetine; oral
2.2
7.1
71
342
N03AX12
ATC
gabapentin; oral
2.0
7.1
99
548
B99
ICD-10 Finland
Other and unspecified infectious diseases
6.1
7.1
18
30
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
12.2
7.1
12
10
ZX140
NOMESCO Finland
Intra articular
8.9
7.1
14
16
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
7.1
79
400
A01AB09
ATC
miconazole; local oral
2.2
7.1
70
335
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
7.7
6.9
15
20
J05AB11
ATC
valaciclovir; oral
2.0
6.8
86
459
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
9.5
6.8
13
14
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
6.8
56
245
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
40.5
6.8
8
*
J05AB01
ATC
aciclovir; systemic
1.8
6.8
137
861
N06AA09
ATC
amitriptyline; systemic
2.2
6.8
68
327
E000001
ATC
NA
1.8
6.7
126
771
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.2
6.7
66
316
M06
ICD-10 Finland
Other rheumatoid arthritis
22.8
6.7
9
*
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6.0
6.6
17
29
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
12.4
6.6
11
9
H25.8
ICD-10 Finland
Other senile cataract
2.2
6.6
65
312
E000002
ATC
NA
2.1
6.5
71
354
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
6.3
6.5
16
26
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
6.5
48
199
S01XA18
ATC
ciclosporin; ophthalmic
14.5
6.4
10
7
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
6.4
102
594
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
5.3
6.4
18
35
NDL52
NOMESCO Finland
Tenosynovectomy of hand
8.3
6.4
13
16
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
8.3
6.4
13
16
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.4
6.3
21
49
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
18.2
6.3
9
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
6.3
212
1531
7109X
ICD-9 Finland
Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease
+∞
6.3
6
*
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
+∞
6.3
6
*
N35.1
ICD-10 Finland
Postinfective urethral stricture, not elsewhere classified
+∞
6.3
6
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
6.2
58
272
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
5.4
6.2
17
32
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
6.2
62
300
TAB00
NOMESCO Finland
Lumbar puncture
3.4
6.2
28
86
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.7
6.1
19
41
H05AA02
ATC
teriparatide; parenteral
10.2
6.0
11
11
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.0
114
700
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.0
6.0
22
56
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.0
6.0
22
56
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.2
6.0
63
309
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
258
122
33.86
307.65
2.1
1.1
u/ml
50.9
4.1
12.73
146
14
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
257
120
34.21
307.65
2.0
1.1
u/ml
17.2
2.4
—
85
9
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
259
134
30.96
307.65
2.0
1.1
u/ml
39.1
1.2
—
38
8
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
224
91
36.56
307.65
2.0
1.1
u/ml
3.2
16.5
—
35
5
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
240
143
25.65
304.91
5.2
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
212
105
29.13
290.76
2.1
1.1
u/ml
52.5
4.2
—
53
9
(3015171) Extractable nuclear Ab [Units/volume] in Serum
215
170
18.19
233.68
2.2
1.2
u/ml
2.0
2.6
0.12
13
11
(3037522) Nuclear Ab [Titer] in Serum
355
708
9.58
193.78
2.2
1.3
titre
1451.5
361.6
18.52
212
148
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
82
36
25.83
114.81
1.5
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
82
36
25.83
114.81
1.5
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
82
36
25.83
114.81
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
82
37
25.13
113.58
1.5
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
82
37
25.13
113.58
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
82
37
25.13
113.58
1.5
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
452
1769
5.82
107.13
13.6
5.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
560
2670
7.84
104.15
15.3
5.1
e9/l
0.6
0.6
0.05
532
2317
(3006315) Basophils [#/volume] in Blood
561
2681
7.87
104.00
15.5
5.1
e9/l
0.0
0.0
1.36
532
2327
(3022096) Basophils/100 leukocytes in Blood
529
2428
6.70
101.80
16.0
5.2
%
0.7
0.7
0.76
517
2256
(3006504) Eosinophils/100 leukocytes in Blood
537
2518
6.81
100.11
15.9
5.2
%
2.5
2.8
2.71
526
2339
(3019069) Monocytes/100 leukocytes in Blood
538
2531
6.82
99.77
16.4
5.4
%
9.5
8.4
12.28
527
2367
(3019198) Lymphocytes [#/volume] in Blood
563
2756
7.69
99.73
15.6
5.1
e9/l
1.6
1.9
10.34
532
2453
(3013115) Eosinophils [#/volume] in Blood
565
2776
7.77
99.62
15.8
5.4
e9/l
0.2
0.2
7.32
536
2457
(3018010) Neutrophils/100 leukocytes in Blood
539
2572
6.71
97.28
15.6
5.1
%
58.9
57.1
3.13
527
2409
(3002030) Lymphocytes/100 leukocytes in Blood
540
2607
6.63
95.30
16.2
5.3
%
26.4
28.3
3.98
528
2425
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
389
1541
4.66
85.24
4.2
2.0
u/l
126.4
221.8
1.41
370
1459
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
53
15
38.30
85.06
1.2
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
575
3129
7.07
82.38
18.0
8.4
e9/l
3.8
4.0
2.10
545
2738
(3028026) IgM [Mass/volume] in Serum or Plasma
154
302
6.33
78.51
2.1
1.7
g/l
1.3
1.4
0.06
148
276
(3021440) Promyelocytes/100 leukocytes in Blood
178
405
5.63
77.26
7.3
4.0
%
0.0
0.2
3.50
51
119
(3025159) Blasts/100 leukocytes in Blood
173
384
5.73
77.18
7.4
4.1
%
0.0
1.0
0.61
48
99
(3017181) Myelocytes/100 leukocytes in Blood
182
435
5.38
74.49
7.3
3.9
%
0.6
1.0
1.58
52
134
(3002179) Metamyelocytes/100 leukocytes in Blood
170
392
5.48
72.34
6.7
3.9
%
0.4
0.6
0.79
43
93
(3004616) Nuclear Ab [Presence] in Serum
62
51
13.30
63.30
1.6
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
335
1426
3.71
61.04
3.7
3.0
ng/l
820.7
1225.1
1.80
305
1200
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
51
33
16.65
59.45
1.6
1.1
u/ml
89.0
—
—
9
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
51
34
16.16
58.53
1.6
1.1
u/ml
64.9
—
—
14
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
91
151
6.82
53.98
2.7
2.1
ug/l
131.3
281.8
1.76
83
142
(4268621)
55
49
12.14
53.29
2.6
2.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
434
2338
3.45
51.47
3.2
2.2
nmol/l
81.2
77.1
2.60
407
2094
(3009261) Glucose [Presence] in Urine by Test strip
475
2751
3.52
49.01
6.8
3.5
estimate
0.0
0.0
0.80
128
497
(3035350) Ketones [Presence] in Urine by Test strip
470
2706
3.49
48.94
6.6
3.5
estimate
0.0
0.0
0.00
122
514
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
63
77
8.93
48.67
1.6
1.1
u/ml
4.5
8.3
0.51
38
29
(3013707) Erythrocyte sedimentation rate by Westergren method
605
4135
5.98
48.46
13.4
3.7
mm/h
14.8
11.9
5.25
586
3811
(3021601) Nitrite [Presence] in Urine by Test strip
469
2723
3.43
47.59
9.3
4.8
estimate
0.0
0.0
0.50
126
511
(40760892) CBC W Ordered Manual Differential panel - Blood
277
1209
3.21
45.59
10.3
4.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
566
3812
4.20
42.99
10.0
4.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
57
74
8.33
41.84
1.8
1.2
u/ml
6.2
5.6
0.05
37
18
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
595
4219
4.80
40.28
15.1
6.8
u/l
71.7
77.6
4.02
585
3952
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
82
164
5.56
39.87
1.6
1.5
iu/ml
0.0
0.1
0.78
13
26
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
439
2615
2.99
39.36
8.1
6.4
mmol/l
1.2
1.2
1.11
383
2207
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
230
985
3.04
37.94
1.4
1.3
iu/ml
55.3
32.7
1.21
93
311
(3004588) Protein electrophoresis panel - Serum or Plasma
116
326
4.10
37.09
1.6
2.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
246
1108
2.93
36.87
1.8
1.5
g/l
2.4
2.4
0.10
191
661
(3020630) Protein [Mass/volume] in Serum or Plasma
128
390
3.82
36.49
2.0
3.2
g/l
67.8
67.0
0.47
121
353
(3021589) Normoblasts [#/volume] in Blood
411
2429
2.80
36.22
18.5
8.5
e9/l
0.0
0.0
0.76
376
1996
(3018095) Leukocytes [#/volume] in Urine
343
1876
2.71
34.83
5.5
3.4
e6/l
105.3
78.4
0.32
246
1308
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
150
540
3.29
32.83
3.5
3.9
u/l
234.0
257.9
0.78
142
512
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
208
933
2.79
30.53
1.4
1.3
u/ml
14.5
10.6
0.30
83
360
(3036481) Cortisol [Moles/volume] in Serum or Plasma
136
494
3.20
29.08
2.0
1.9
nmol/l
348.3
387.1
0.94
129
457
(42529582) MDA5 Ab [Presence] in Serum by Line blot
35
8
46.01
28.95
1.2
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
35
8
46.01
28.95
1.2
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
35
8
46.01
28.95
1.2
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
35
8
46.01
28.95
1.2
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
27
11.59
28.63
1.4
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
42
60
7.40
28.28
1.7
1.4
g/l
0.8
0.6
0.52
30
47
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
385
2381
2.46
28.14
6.4
5.7
mmol/l
1.2
1.2
0.59
356
2155
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
23
14
16.98
27.28
2.1
1.3
ug/l
7.6
8.3
0.55
23
14
(3011412) CD3 cells [#/volume] in Blood
32
34
9.84
27.26
2.2
2.2
e9/l
0.8
1.1
0.49
20
14
(3004789) Transferrin [Mass/volume] in Serum or Plasma
169
725
2.78
26.60
2.8
2.3
g/l
2.3
2.4
0.24
158
672
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
158
671
2.78
25.23
2.8
2.3
%
19.5
22.4
1.93
142
580
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
25
21
12.33
24.85
2.2
2.6
%
8.9
11.6
—
8
11
(3022948) Iron [Moles/volume] in Serum or Plasma
175
794
2.63
24.44
3.0
2.3
umol/l
11.1
13.1
3.70
166
725
(3017143) Hepatitis C virus Ab [Presence] in Serum
145
598
2.82
24.42
1.4
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
50
99
5.38
24.39
5.1
3.0
e9/l
3.8
4.3
0.72
50
99
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
34
9.19
24.34
1.5
1.4
g/l
2.4
2.6
0.20
23
23
(3041096) Erythrocytes [Presence] in Urine by Automated
272
1514
2.35
24.28
6.7
3.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
179
4.18
24.27
1.8
2.5
g/l
3.6
3.8
0.47
50
133
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
179
4.18
24.27
1.8
2.5
g/l
7.0
7.5
1.43
51
139
(3002582) Erythrocytes [#/volume] in Urine
278
1569
2.32
23.95
4.6
2.9
e6/l
26.9
105.2
1.12
238
1200
(3030467) Casts [#/volume] in Urine by Automated count
261
1435
2.35
23.89
4.2
2.8
e6/l
0.2
0.5
3.15
220
1071
(3000850) Epithelial cells [#/volume] in Urine
214
1082
2.44
23.65
3.2
2.4
e6/l
3.6
7.2
3.73
188
956
(3023368) Bacteria identified in Blood by Culture
246
1325
2.36
23.55
4.9
3.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
179
4.12
23.44
1.8
2.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
166
4.23
23.33
1.8
2.5
g/l
13.5
10.9
2.05
58
145
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
50
103
5.17
23.32
5.5
3.2
%
59.3
59.3
0.00
50
103
(4062490)
30
36
8.68
23.29
1.8
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
21
11.82
23.24
2.7
2.6
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
29
34
8.87
22.92
1.6
1.4
g/l
0.3
0.4
0.12
22
23
(3027135) IgG subclass 1 [Mass/volume] in Serum
29
34
8.87
22.92
1.6
1.4
g/l
8.8
5.8
1.31
22
23
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
76
225
3.68
22.19
1.8
2.2
u/l
40.6
40.7
0.02
68
202
(3017732) Neutrophils [#/volume] in Blood
102
376
3.02
20.89
3.9
2.4
e9/l
3.7
4.0
0.44
71
304
(3026782) Osmolality of Urine
201
1036
2.35
20.89
4.3
2.5
mosm/kgh2o
524.7
541.3
0.51
178
887
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
320
1997
2.16
20.72
4.5
3.5
ng/l
23.3
53.3
0.94
231
1312
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
167
3.99
20.68
1.8
2.5
g/l
3.1
3.1
0.01
51
135
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
412
2838
2.18
20.62
5.9
5.7
umol/l
9.4
10.5
2.29
392
2689
(36304419) Bacteria [Presence] in Urine
248
1405
2.22
20.47
3.7
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
331
2111
2.13
20.06
7.3
3.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
100
378
2.94
19.54
2.8
2.9
ng/l
78.3
185.7
6.02
92
344
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
24
27
9.18
19.53
1.3
1.1
ratio
1.1
1.1
—
12
9
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
18
13
14.20
19.41
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
128
558
2.60
18.99
2.9
2.6
%
1.7
1.8
0.63
116
501
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
55
146
4.02
18.70
1.9
2.5
g/l
36.4
38.1
1.14
49
128
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
55
146
4.02
18.70
2.5
2.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
51
129
4.20
18.49
1.3
1.2
titre
156.0
65.8
—
5
12
(3029937) Albumin [Presence] in Urine by Test strip
250
1473
2.12
18.24
7.1
3.7
estimate
0.0
0.0
0.80
125
506
(3011397) Hemoglobin [Presence] in Urine by Test strip
222
1251
2.16
18.17
5.4
3.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
36
70
5.38
17.87
1.6
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
101
406
2.75
17.52
2.7
2.7
e9/l
69.1
72.6
0.41
73
312
(3018418) pH of Serum or Plasma
260
1583
2.05
17.14
4.0
3.7
ph
7.4
7.4
1.05
55
299
(40758558) Short blood count panel - Blood
233
1365
2.09
17.03
12.0
6.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
231
1358
2.07
16.66
2.9
2.1
mg/l
3.3
3.0
0.74
202
1158
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
67
220
3.27
16.59
2.5
2.0
g/l
1.6
1.5
0.50
62
192
(3042936) Bacteria identified in Isolate by Culture
149
744
2.29
16.21
2.3
2.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
18
18
10.25
15.87
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
157
814
2.21
15.53
2.1
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
224
1334
2.02
15.36
2.8
2.6
umol/l
1740.9
6706.6
2.46
207
1152
(40768797) Stomach Pathology biopsy report
154
799
2.21
15.18
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
95
400
2.60
14.96
1.2
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
34
75
4.72
14.62
2.0
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
262
1679
1.92
14.31
3.0
2.3
u/l
58.3
56.1
0.39
248
1560
(3024561) Albumin [Mass/volume] in Serum or Plasma
330
2281
1.88
14.26
5.7
4.3
g/l
34.6
35.8
3.44
315
2125
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
208
1240
1.98
14.00
1.9
1.6
mg/l
1.1
1.1
0.18
183
956
(3007853) Bacteria identified in Skin by Aerobe culture
125
614
2.27
13.98
2.1
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
159
861
2.11
13.94
3.5
2.5
e6/l
1.3
1.1
0.17
110
467
(3032080) INR in Blood by Coagulation assay
305
2069
1.87
13.86
10.8
7.8
inr
1.2
1.2
0.31
90
608
(40768443) Skin Pathology biopsy report
64
229
2.99
13.68
1.3
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
96
427
2.46
13.42
3.8
3.6
mmol/l
1.2
1.2
0.71
84
372
(3013512) EKG study
240
1527
1.89
13.16
5.1
3.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
43
123
3.67
13.15
1.8
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
18
8
23.07
12.95
2.1
2.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
467
3679
1.90
12.67
5.6
4.4
e6/l
653.8
3074.0
—
6
60
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
11
12.03
12.67
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
48
5.37
12.57
2.3
1.5
%
49.3
62.9
0.85
20
33
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
39
108
3.77
12.49
1.6
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
33
81
4.23
12.44
2.0
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
60
219
2.91
12.37
2.0
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
146
800
2.06
12.25
4.3
2.7
e6/l
5.2
3.6
0.49
95
409
(3037756) Immunofixation for Serum or Plasma
38
105
3.78
12.21
1.3
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
130
684
2.12
12.15
2.2
2.2
ug/g
226.7
122.8
0.91
106
530
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
156
881
2.01
12.02
1.6
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
35
93
3.92
11.88
1.4
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
83
367
2.44
11.71
2.0
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
7
23.37
11.61
2.3
3.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
624
5543
2.95
11.51
29.9
12.6
mg/l
17.1
21.9
4.70
563
4337
(3001122) Ferritin [Mass/volume] in Serum or Plasma
348
2556
1.76
11.39
3.7
2.7
ug/l
138.9
101.7
0.95
323
2365
(3019309) Folate [Moles/volume] in Red Blood Cells
170
1008
1.92
11.29
1.9
1.7
nmol/l
989.3
1180.7
2.22
131
754
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
119
3.42
10.84
1.2
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
120
642
2.06
10.64
1.9
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
302
2167
1.72
10.45
2.1
2.0
pmol/l
93.7
96.3
0.44
165
1084
(3000475) Leukocytes [#/volume] in Synovial fluid
36
107
3.50
10.41
1.9
1.7
e6/l
7303.1
17255.2
0.79
27
76
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
260
1796
1.73
10.28
3.9
2.9
u/l
33.4
29.7
1.33
249
1705
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
35
5.56
9.97
2.1
1.4
%
49.3
40.4
0.36
13
23
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
30
81
3.83
9.97
1.4
1.4
u/ml
110.4
114.6
—
5
20
(3019225) pH of Specimen
104
540
2.10
9.96
5.7
4.1
—
—
—
0
0
(4306422)
28
72
4.02
9.94
1.3
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
50
187
2.81
9.87
2.0
1.9
ug/l
2.8
2.7
0.01
44
169
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
42
143
3.07
9.79
1.8
4.5
mg/l
36.7
49.2
0.23
35
113
(3034860) Kappa light chains.free [Mass/volume] in Serum
42
143
3.07
9.79
1.8
4.5
mg/l
42.3
93.0
0.58
36
113
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
14
8
17.84
9.43
1.4
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
41
141
3.03
9.40
1.8
4.5
ratio
1.3
2.2
—
6
15
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
58
4.26
9.24
2.4
4.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
393
3094
1.66
9.08
5.3
4.5
mmol/l
6.4
6.6
1.10
376
2874
(3003458) Phosphate [Moles/volume] in Serum or Plasma
113
626
1.97
9.02
6.7
5.2
mmol/l
1.0
1.0
0.11
105
574
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
88
3.52
8.87
1.1
1.3
u/ml
275.9
261.0
0.08
17
50
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
40
4.86
8.63
1.6
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
557
1.98
8.46
2.1
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
96
3.34
8.44
1.1
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
140
2.90
8.31
1.9
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
23
6.20
8.21
1.4
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
23
6.20
8.21
1.4
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
206
2.54
8.19
2.0
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
91
483
2.02
8.16
2.8
2.1
g/l
0.2
0.2
0.01
80
455
(3021960) Folate [Moles/volume] in Serum or Plasma
191
1277
1.69
8.15
1.6
1.5
nmol/l
22.2
21.4
0.23
159
1091
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
194
1303
1.69
8.14
1.4
1.3
u/ml
1.0
2.2
1.26
48
333
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
142
2.85
8.11
1.3
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
20
6.61
8.09
1.0
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
51
4.22
8.05
2.2
3.4
%
65.8
55.1
1.45
16
37
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
63
293
2.27
7.91
1.8
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
156
2.73
7.86
1.2
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
66
3.73
7.80
3.7
2.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
17
36
4.82
7.67
2.2
1.9
e6/l
469.0
670.2
—
9
14
(46235355) HIV 1 and 2 tests - Meaningful Use set
162
1051
1.72
7.67
1.6
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
75
380
2.10
7.62
2.3
2.4
—
15.3
—
0
16
(40768446) Kidney Pathology biopsy report
10
12
8.44
7.60
1.6
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
166
2.63
7.49
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
100
566
1.90
7.44
2.1
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
412
2.04
7.43
3.4
3.7
ng/l
95.9
79.0
0.37
69
363
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
161
2.65
7.41
1.5
1.4
ug/g
308.6
301.2
0.07
24
93
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
583
5220
1.93
7.39
21.7
11.8
ml/min/173m2
84.2
82.0
1.58
536
4245
(3006184) Hemoglobin [Mass/volume] in Capillary blood
31
105
3.05
7.32
2.6
2.0
g/l
134.4
129.5
0.45
19
75
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
19
6.41
7.26
4.6
3.4
u/ml
2330.4
713.5
0.94
12
19
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
34
4.80
7.19
3.3
2.9
%
61.8
51.5
—
5
8
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
16
6.97
7.17
1.1
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
68
345
2.08
6.88
1.4
1.2
u/ml
60.8
203.9
1.32
58
320
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
45
192
2.44
6.87
2.0
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
30
104
2.97
6.82
1.6
5.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
56
264
2.22
6.82
6.5
3.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
88
3.16
6.81
1.6
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
252
1873
1.56
6.75
3.0
3.2
mmol/l
2.3
2.4
2.38
212
1641
(3026008) Bacteria identified in Urine by Culture
238
1750
1.56
6.67
3.7
2.9
—
—
—
0
0
(44806071)
11
9
12.40
6.60
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
50
3.88
6.57
1.3
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
33
124
2.75
6.50
1.4
1.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
11
18
6.20
6.44
2.1
1.3
%
2.4
1.4
—
5
5
(40761536) Microorganisms panel - Urine sediment
85
480
1.88
6.35
6.0
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
62
314
2.07
6.31
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
36
144
2.59
6.29
6.7
4.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
87
3.07
6.29
3.2
2.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
5
18.22
6.28
1.0
6.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
115
2.78
6.26
1.7
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
80
446
1.90
6.21
4.1
3.3
mmol/l
2.4
1.9
0.61
70
351
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
123
2.68
6.05
1.7
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
95
2.92
6.00
1.1
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
10
16
6.33
5.97
1.5
1.2
g/l
36.0
39.2
—
5
10
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
40
4.07
5.92
1.1
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
81
3.04
5.74
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
71
3.17
5.66
1.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
39
172
2.35
5.57
2.5
3.0
g/l
0.8
0.2
1.05
16
62
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
123
2.59
5.53
5.1
2.5
u/ml
0.5
0.4
0.78
22
72
(3019150) Specific gravity of Urine by Refractometry
171
1212
1.55
5.48
7.1
3.8
kg/l
1.0
1.0
0.91
25
167
(3000093) Morphology [Interpretation] in Blood Narrative
15
38
4.02
5.46
1.2
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
38
4.02
5.46
1.3
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
68
375
1.91
5.46
4.0
2.6
kpa
4.3
4.5
0.24
68
360
(3044927) Protein electrophoresis panel - Urine
16
43
3.79
5.39
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
161
1130
1.56
5.38
1.6
1.7
pmol/l
56910992.6
27177776.1
0.21
123
953
(36660697) Celiac disease serology panel - Serum
79
460
1.81
5.36
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
63
3.24
5.35
1.6
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
91
2.82
5.26
4.0
3.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
35
4.06
5.19
2.0
2.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
70
3.07
5.14
1.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
32
134
2.46
5.13
1.2
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
31
4.26
5.11
1.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
88
537
1.74
5.09
6.1
8.2
mmol/l
0.7
1.3
0.60
73
424
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
88
537
1.74
5.09
6.1
8.1
kpa
4.8
5.1
2.34
83
516
(3019174) dRVVT (LA screen)
8
6
13.47
5.09
1.1
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
76
2.96
5.07
1.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
55
290
1.98
5.04
4.8
3.5
mmol/l
1.8
1.9
0.03
42
220
(3022145) Colonoscopy Study observation
99
627
1.68
5.01
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
96
605
1.69
4.94
2.1
2.4
umol/l
6.3
7.1
0.20
84
514
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
89
2.76
4.89
1.8
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
23
84
2.80
4.82
1.3
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
47
3.46
4.77
1.8
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
38
3.74
4.66
1.1
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
104
2.56
4.60
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
104
2.56
4.60
1.3
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
34
3.88
4.55
1.5
1.5
u/l
8.4
8.0
—
8
17
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
499
4455
1.48
4.52
5.0
4.2
pmol/l
14.8
14.7
0.62
454
4065
(3009343) pH of Capillary blood
55
302
1.89
4.50
4.9
3.5
ph
7.4
7.4
—
6
37
(3033658) Prothrombin time (PT) actual/Normal
180
1342
1.47
4.42
4.7
3.4
%
94.8
94.1
0.14
175
1309
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
624
5883
1.94
4.38
24.3
9.7
u/l
25.3
24.5
0.84
613
5676
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
26
4.28
4.37
1.6
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
83
2.71
4.36
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
50
3.25
4.36
5.4
4.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
72
2.83
4.32
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
136
962
1.52
4.31
4.4
3.7
ng/l
300.2
288.6
0.02
108
711
(3028433) Virus identified in Specimen by Culture
10
22
4.60
4.31
1.1
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
22
4.60
4.31
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
22
4.60
4.31
1.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
133
2.31
4.28
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
70
421
1.74
4.27
6.3
3.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
46
3.31
4.21
1.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
46
3.31
4.21
1.1
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
46
3.31
4.21
1.1
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
284
2321
1.39
4.13
2.2
2.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
23
4.40
4.10
1.2
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
121
845
1.53
4.06
3.3
3.1
mmol/l
0.8
0.8
1.31
110
783
(3044640) Blood type and Crossmatch panel - Blood
223
1753
1.41
4.06
2.9
2.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
14
6.50
3.99
1.9
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
53
3.07
3.99
1.8
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
54
3.01
3.87
3.9
2.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
18
67
2.73
3.68
4.8
2.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
67
2.73
3.68
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
12
6.73
3.68
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
62
2.79
3.61
1.2
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
18
68
2.69
3.59
4.8
2.5
mmol/l
107.0
106.0
0.60
18
68
(3041354) Potassium [Moles/volume] in Venous blood
18
68
2.69
3.59
4.8
2.5
mmol/l
4.1
4.0
0.18
18
68
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
80
2.55
3.57
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
80
2.55
3.57
1.4
1.4
—
—
—
0
0
(4035726)
73
467
1.63
3.57
1.5
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
17
5.35
3.52
1.8
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
6
10.07
3.50
1.2
1.2
—
—
—
0
0
(4027681)
12
36
3.38
3.49
1.3
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
47
269
1.80
3.42
2.7
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
172
1328
1.40
3.39
2.7
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
23
101
2.32
3.39
1.2
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
599
5645
1.60
3.37
23.4
14.7
mmol/l
139.4
139.6
1.65
587
5495
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
48
2.96
3.31
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
48
2.96
3.31
1.2
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
7
8.63
3.27
5.2
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
38
3.20
3.22
1.5
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
11
6.42
3.19
1.1
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
40
223
1.84
3.18
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
55
2.77
3.17
1.5
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
13
44
2.99
3.15
1.1
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
599
5663
1.57
3.10
23.6
14.8
mmol/l
3.9
4.0
1.31
584
5497
(3000991) Gas panel - Venous blood
61
387
1.63
3.10
8.2
7.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
51
309
1.70
3.08
2.7
6.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
40
226
1.82
3.06
5.2
3.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
29
3.49
3.05
1.1
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
29
3.49
3.05
1.1
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
29
3.49
3.05
1.1
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
29
3.49
3.05
1.1
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
28
140
2.04
3.05
2.1
3.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
40
3.04
2.98
1.9
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
306
2620
1.31
2.98
4.2
4.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
507
4664
1.36
2.92
31.9
15.7
%
14.1
13.6
8.15
501
4581
(21494755) Public health laboratory ask at order entry panel
32
565
0.54
2.91
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
58
2.62
2.89
2.3
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
18
4.48
2.80
1.9
1.2
—
—
—
0
0
(3000492) Spirometry study
76
522
1.51
2.77
1.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
78
2.34
2.76
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
78
2.34
2.76
1.3
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
34
189
1.84
2.76
5.3
4.0
mmol/l
24.6
25.0
0.37
29
182
(3021901) Oxygen saturation in Capillary blood
19
85
2.27
2.72
3.7
2.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
10
6.04
2.70
4.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
79
2.31
2.69
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
79
2.31
2.69
1.3
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
92
2.21
2.69
3.6
2.3
%
17.0
15.8
0.56
12
43
(3003327) Ova and parasites identified in Stool by Light microscopy
34
192
1.81
2.63
1.9
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
55
2.58
2.63
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
80
2.28
2.62
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
93
673
1.44
2.62
4.9
4.3
%
33.1
32.7
0.11
72
444
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
62
413
1.55
2.60
2.3
2.3
ug/l
7.3
7.1
0.03
46
359
(3013727) Leukocytes other/100 leukocytes in Blood
7
15
4.70
2.60
6.0
4.3
%
63.6
47.9
—
7
15
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
11
38
2.93
2.59
1.8
1.3
mmol/l
1.8
2.0
0.81
11
38
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
11
5.49
2.55
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
50
2.63
2.54
1.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
33
3.06
2.53
2.1
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
49
311
1.62
2.52
1.3
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
28
152
1.88
2.46
1.3
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
27
3.36
2.40
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
58
2.44
2.38
2.1
2.6
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
8
6.29
2.37
1.0
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
86
627
1.43
2.34
29.9
21.3
inr
1.6
1.2
—
7
84
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
30
504
0.58
2.32
1.9
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
28
3.24
2.31
2.2
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
173
0.34
2.29
1.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
29
3.13
2.23
2.2
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
73
2.22
2.22
2.0
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
9
5.59
2.21
1.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
9
5.59
2.21
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
54
2.44
2.21
1.5
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
11
42
2.65
2.19
1.6
1.2
e6/l
6183.3
53201.2
—
6
22
(40761511) CBC panel - Blood by Automated count
606
5811
1.47
2.18
23.4
12.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
19
3.71
2.15
1.3
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
39
245
1.63
2.12
3.4
2.2
%
1.1
1.2
0.76
39
245
(3020961) Endomysium IgA Ab [Titer] in Serum
44
285
1.58
2.12
1.1
1.1
—
163.9
—
0
8
(3044889) 12 lead EKG panel
416
3799
1.25
2.10
4.3
3.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
238
1.63
2.09
10.2
12.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
10
5.03
2.07
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
10
5.03
2.07
1.2
1.1
%
88.0
102.2
—
5
10
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
20
3.53
2.06
1.1
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
20
3.53
2.06
1.1
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
20
3.53
2.06
1.1
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
53
361
1.51
2.05
2.6
3.3
pmol/l
4.2
4.6
1.32
44
314
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
396
3602
1.24
2.05
3.3
3.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
15
4.03
2.04
1.5
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
26
148
1.79
2.01
1.9
1.2
mg/l
620.3
463.1
0.69
26
139
(3022621) pH of Urine by Test strip
50
339
1.51
1.98
4.6
2.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
11
4.57
1.94
1.0
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
11
4.57
1.94
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
11
4.57
1.94
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
16
3.77
1.94
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
16
3.77
1.94
1.0
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
186
1570
1.26
1.86
4.8
3.9
mg/mmol
15.6
8.3
0.59
129
966
(3024471) HLA-A [Type]
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
12
4.19
1.82
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
23
3.06
1.80
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
400
3672
1.22
1.78
4.2
2.9
u/l
52.5
45.6
0.78
375
3438
(3014051) Protein [Presence] in Urine by Test strip
21
117
1.82
1.76
1.5
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
24
2.94
1.72
1.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
204
1.60
1.68
1.7
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
62
2.12
1.66
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
112
1.81
1.66
1.9
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
25
2.82
1.65
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
350
0.59
1.63
1.6
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
66
494
1.37
1.59
2.4
2.2
u/l
31.4
34.5
0.32
57
403
(3043410) Blood group antigens tested for on Red Blood Cells
6
20
3.02
1.58
2.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
33
2.44
1.54
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
7
27
2.61
1.52
1.1
1.6
—
—
—
0
0
(3010421) pH of Blood
20
116
1.75
1.50
5.6
2.8
ph
7.4
7.4
0.26
20
97
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
139
1.68
1.50
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
58
2.09
1.50
1.2
1.4
pmol/l
346.0
368.9
0.06
12
46
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
547
5230
1.26
1.46
6.2
5.0
mu/l
1.9
2.1
0.29
505
4799
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
653
0.71
1.45
1.9
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
19
111
1.73
1.40
3.8
2.6
kpa
8.0
8.0
0.06
19
103
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
74
1.91
1.40
1.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
41
2.21
1.37
2.3
3.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
23
2.62
1.37
2.2
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
75
1.89
1.35
1.3
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
54
2.05
1.33
1.6
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
83
1.83
1.32
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
26
169
1.56
1.30
1.7
2.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
24
2.51
1.30
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
172
1492
1.21
1.30
3.6
3.2
mg/l
958.4
226.0
0.59
106
929
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
91
1.78
1.30
1.0
1.1
—
12.6
—
0
7
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
34
2.37
1.29
1.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
34
2.37
1.29
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
18
2.79
1.28
5.6
4.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
78
1.81
1.22
1.1
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
19
2.64
1.22
1.6
1.7
ug/l
70.7
50.7
—
5
19
(3009508) Creatinine [Moles/volume] in Urine
182
1598
1.19
1.21
3.7
3.1
mmol/l
6.7
7.2
0.73
149
1339
(3015183) Erythrocyte sedimentation rate
6
26
2.32
1.19
1.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
26
2.32
1.19
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
26
2.32
1.19
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
64
1.89
1.18
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
630
6164
1.40
1.18
41.3
19.1
e9/l
255.5
255.4
0.02
621
6016
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
120
1015
1.22
1.17
2.8
2.7
mmol/l
2.5
2.4
0.59
107
897
(44790049)
11
57
1.95
1.17
1.7
1.4
—
—
—
0
0
(44790047)
11
57
1.95
1.17
1.7
1.4
—
—
—
0
0
(44806118)
11
57
1.95
1.17
1.7
1.4
—
—
—
0
0
(44790048)
11
57
1.95
1.17
1.7
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
630
6166
1.39
1.16
40.9
19.1
fl
91.7
90.9
4.46
624
6079
(4024509)
8
39
2.06
1.15
1.6
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
630
6168
1.39
1.13
40.8
19.0
pg
30.2
30.2
0.11
623
6080
(3026361) Erythrocytes [#/volume] in Blood
630
6168
1.39
1.13
41.0
19.1
e12/l
4.4
4.4
6.33
619
6001
(21494890) Protein electrophoresis panel - 24 hour Urine
10
51
1.98
1.11
1.5
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
128
1096
1.21
1.11
1.4
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
630
6170
1.38
1.11
41.3
19.2
g/l
130.5
133.8
7.72
622
6077
(3010813) Leukocytes [#/volume] in Blood
630
6170
1.38
1.11
41.1
19.1
e9/l
6.4
6.6
1.98
617
6000
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
140
0.49
1.10
2.0
1.7
—
—
—
0
0
(4211845)
5
21
2.39
1.09
5.6
3.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
59
1.88
1.08
1.7
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
46
1.97
1.04
1.4
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
58
458
1.29
1.03
1.2
1.2
iu/ml
70.9
139.3
1.68
19
191
(3013005) Retinol [Moles/volume] in Serum or Plasma
5
22
2.28
1.03
1.6
1.6
umol/l
1.4
2.0
—
5
22
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
62
1.79
0.94
1.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
37
1.90
0.94
1.6
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
52
1.74
0.92
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
28
2.15
0.91
2.8
3.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
152
0.59
0.89
1.3
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
29
2.08
0.89
2.8
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
525
5070
1.17
0.89
27.7
13.8
%
37.7
39.6
3.77
345
3725
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
68
560
1.24
0.88
4.0
3.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
30
2.01
0.87
1.2
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
44
1.83
0.86
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
179
1.41
0.85
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
74
621
1.22
0.82
1.4
1.7
%
1.7
1.4
1.07
66
547
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
32
1.88
0.82
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
32
1.88
0.82
1.3
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
33
1.83
0.79
1.3
1.4
—
24.0
—
0
5
(3019230) Fractional oxyhemoglobin in Venous blood
14
90
1.57
0.78
3.4
1.7
%
55.2
60.6
0.41
14
90
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1470
0.86
0.78
1.6
1.6
mmol/l
1.4
1.4
0.04
110
1253
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
34
1.77
0.76
1.0
1.4
—
275.0
—
0
6
(1002224) Polysomnography panel
18
254
0.70
0.74
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
55
1.64
0.73
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
52
426
1.24
0.73
5.6
2.5
ml/min/173m2
61.3
67.6
0.50
24
172
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
44
542
0.80
0.72
2.2
2.9
ug/l
1.0
0.8
0.35
26
359
(3035880) pH of Pleural fluid
5
26
1.93
0.70
1.6
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
110
1.47
0.69
2.5
2.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
27
1.86
0.68
2.2
2.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
28
1.79
0.66
2.0
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
129
1159
1.14
0.65
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
166
0.66
0.65
1.4
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
146
1.38
0.64
1.8
1.9
iu/l
4.2
5.2
—
6
47
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
181
1.34
0.64
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
54
1.49
0.57
2.0
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
185
1.31
0.57
1.3
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
55
1.46
0.56
1.6
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
37
1.63
0.55
1.7
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
37
1.63
0.55
1.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
38
1.58
0.54
1.2
2.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
9
61
1.48
0.54
2.2
1.8
%
86.4
89.8
—
9
61
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
547
5579
0.89
0.52
4.9
4.8
mmol/l
2.6
2.8
6.75
511
5159
(1761868) Lipid panel - Serum or Plasma
188
2006
0.91
0.48
2.9
2.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
48
1.46
0.47
1.3
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
82
0.61
0.46
1.4
1.3
ug/l
3.7
3.1
—
5
70
(4010399)
45
385
1.18
0.46
1.7
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
69
1.46
0.44
1.2
2.1
u/ml
33.8
64.3
—
10
63
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
229
0.78
0.43
1.7
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
32
1.57
0.42
1.4
3.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
0.7
—
0
9
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
2.3
—
0
6
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
34
1.47
0.40
3.6
1.4
promille
1.2
1.4
—
5
25
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
193
0.77
0.39
1.4
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
215
0.79
0.39
1.7
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
114
0.70
0.37
1.3
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
5
37
1.35
0.37
1.2
2.0
ml
745.6
509.6
—
5
22
(3004716) Salmonella sp identified in Stool by Organism specific culture
38
328
1.17
0.37
1.4
1.3
—
—
—
0
0
(44813793)
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
144
0.76
0.33
1.8
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
144
0.76
0.33
1.8
1.4
—
—
—
0
0
(4146454)
6
47
1.28
0.32
2.5
2.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
175
0.80
0.31
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
175
0.80
0.31
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
175
0.80
0.31
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
175
0.80
0.31
1.6
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
98
0.71
0.31
1.6
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
34
299
1.14
0.28
1.2
1.2
iu/l
36.3
29.6
0.42
27
255
(3001019) Free T4 and TSH panel - Serum or Plasma
30
342
0.87
0.27
1.9
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
76
705
1.09
0.26
1.2
1.2
—
—
—
0
0
(4034850)
15
180
0.83
0.24
23.7
8.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
303
1.13
0.24
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
513
5062
1.06
0.23
5.9
5.5
mmol/mol
38.8
39.4
0.95
475
4707
(3003129) Base excess in Capillary blood by calculation
0
10
0.00
0.21
0.0
1.3
—
3.4
—
0
10
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
1.7
—
0
10
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
101
0.79
0.21
1.5
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
43
1.16
0.21
1.6
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
43
1.16
0.21
1.6
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
64
686
0.93
0.21
1.8
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
43
393
1.10
0.21
1.7
1.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
48
1.25
0.20
1.0
1.5
ug/l
14.1
20.5
—
6
48
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
14
0.00
0.20
0.0
1.9
—
1.2
—
0
14
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
51
1.18
0.19
4.7
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
59
1.19
0.18
1.4
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
98
935
1.06
0.17
3.8
4.8
ug/l
1.3
2.5
2.53
82
834
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
70
740
0.94
0.16
2.7
4.3
%
24.0
21.4
0.78
28
347
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
69
1.16
0.16
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
69
1.16
0.16
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
540
5447
0.95
0.16
4.6
4.2
mmol/l
1.5
1.5
0.38
501
5043
(3020891) Body temperature
21
188
1.12
0.15
3.6
4.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
563
0.94
0.15
1.3
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
529
5246
1.04
0.14
4.2
3.8
mmol/l
1.3
1.3
0.69
488
4821
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
29
315
0.92
0.13
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
149
0.87
0.13
1.8
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
94
1.17
0.13
1.3
1.1
u/ml
0.7
1.4
—
5
31
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
314
0.92
0.13
1.6
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
229
1.10
0.12
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
59
619
0.95
0.12
1.5
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
198
0.91
0.11
1.2
1.3
miu/ml
383.3
263.6
—
7
95
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
239
0.92
0.10
1.8
2.1
u/l
118.4
2435.3
—
9
100
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
187
0.91
0.10
1.7
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
155
0.90
0.09
1.3
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
55
1.09
0.09
4.2
10.6
mmol/l
6.3
6.7
—
6
42
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
545
5478
0.97
0.08
4.5
4.3
mmol/l
4.5
4.7
6.27
507
5096
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
117
1.11
0.08
1.9
2.2
ug/min
729.4
111.0
—
7
70
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
65
1.08
0.08
1.9
1.5
—
—
—
0
0
(4281824)
7
65
1.08
0.08
1.6
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
71
0.84
0.07
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
539
5364
1.03
0.07
4.7
4.4
mmol/l
5.7
5.9
3.83
487
4913
(3013139) Helicobacter pylori Ag [Presence] in Stool
41
393
1.05
0.07
1.4
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
87
1.03
0.07
2.7
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
87
1.03
0.07
1.2
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
90
0.89
0.07
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
20
187
1.07
0.06
1.3
3.1
u/ml
30.0
961.8
0.68
15
159
(3003694) ABO and Rh group [Type] in Blood
154
1564
0.98
0.06
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
54
524
1.03
0.05
2.7
3.9
ug/l
3.0
18.1
1.16
48
429
(4094501)
13
139
0.93
0.03
1.3
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
158
0.95
0.02
1.3
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
67
661
1.02
0.02
9.0
6.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
19
184
1.03
0.00
1.3
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
105
1.05
0.00
1.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
115
1.04
0.00
2.8
4.1
mg/l
21.8
30.5
—
5
71
(3027008) Opiates [Presence] in Urine
19
194
0.98
0.00
1.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
194
0.98
0.00
1.3
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
196
1.02
0.00
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
193
0.98
0.00
1.3
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
128
1.02
0.00
1.3
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
60
603
0.99
0.00
1.5
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
24
241
1.00
0.00
1.9
2.0
nmol/l
12.0
12.5
0.12
19
217
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
9.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
84.4
—
0
8
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
79
0.88
0.00
1.3
1.2
nmol/l
0.5
0.5
—
7
74
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
2.4
—
0.6
—
0
7
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.5
—
0
5
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
40.0
—
0
6
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
9.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
73
0.96
0.00
1.3
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_OVERLAP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_OVERLAP | 1.678 [1.46, 1.93] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.224 |
During the follow-up period (1.1.1998 — 31.12.2019), 518 out of 2397 females with M13_OVERLAP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_OVERLAP | 1.774 [1.42, 2.21] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 209 out of 661 males with M13_OVERLAP died.
Mortality risk
Mortality risk for people of age
years, who have M13_OVERLAP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.153% | 0.263% |
| 5 | 1.046% | 1.899% |
| 10 | 2.575% | 4.915% |
| 15 | 4.769% | 8.96% |
| 20 | 8.273% | 15.286% |
Relationships between endpoints
↥Index endpoint: M13_OVERLAP – Other overlap syndromes
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data